What does this research mean for the field?

Anti-spike IgG avidity enhances the neutralization potency of SARS-CoV-2 in individuals with primary infections and those who have been immunized. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

The study aims to evaluate how anti-spike IgG avidity affects the neutralization potency against SARS-CoV-2.

March 7, 2026Open Access

Anti-spike IgG Avidity Enhances Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2: A Prospective Study of Primary Infections and Immunizations

Key Points

The study aims to evaluate how anti-spike IgG avidity affects the neutralization potency against SARS-CoV-2.
Analyzed serological profiles from early primary infections of SARS-CoV-2 and vaccinations.
Measured anti-spike IgG avidity levels in samples.
Assessed the antiviral neutralization potency of samples based on avidity levels.
Higher anti-spike IgG avidity correlates with increased neutralization potency.
The enhancement of neutralization was consistent across different infection and immunization stages.

Abstract

Comprehensive serological profiles of early SARS-CoV-2 primary infections and immunizations provided a model showing that the antiviral neutralization potency is enhanced by anti-spike IgG avidity. The methodology presented is applicable widely beyond COVID-19.

Anti-spike IgG Avidity Enhances Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2: A Prospective Study of Primary Infections and Immunizations

Key Points

Abstract

Cite This Study